WVE
Wave Life Sciences Ltd
3.80$
-4.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +37.5% | -14.4% | -11.2% | +71.7% | -1.8% | -18.1% | -12.5% | -4.3% | +164.5% | -8.6% | -4.3% | |
| – | +48.4% | -16.4% | -12.5% | +88.6% | -1.3% | -19.5% | -13.3% | -3.6% | +185.3% | -8.7% | -9.6% | |
| – | +43.2% | -9.7% | -14.9% | +102.0% | -2.9% | -19.5% | -14.2% | -5.9% | +206.8% | -9.5% | -32.4% | |
| – | +43.2% | -9.7% | -14.9% | +102.0% | -2.9% | -19.5% | -14.2% | -5.9% | +206.8% | -9.5% | -9.9% | |
| – | +201.2% | -100.0% | – | -100.0% | – | +0.0% | +13.7% | +518.4% | -87.2% | -100.0% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -2.1% | -10.8% | -2.6% | +2.2% | -31.7% | -18.3% | -3.0% | +3.3% | -3.9% | -36.0% | +45.9% | |
| – | +86.5% | -11.0% | +4.4% | -1.4% | -35.0% | -21.3% | +0.0% | -1.7% | +10.7% | -47.6% | +2.0% | |
| – | +3.3% | +3.3% | +3.3% | +3.3% | +3.2% | +3.2% | +3.2% | +3.2% | -0.4% | -0.4% | -57.9% | |
| – | +1.8% | -8.6% | +54.7% | -29.6% | +27.2% | -11.7% | +2.1% | -1.2% | +8.4% | +21.4% | +6.8% | |
| – | – | -35.9% | -82.7% | +3,300.4% | +40.1% | -18.0% | -18.9% | -10.6% | +322.5% | -2.8% | -11.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | +17.9% | +0.2% | +2.3% | +30.0% | -5.7% | +0.9% | +2.3% | +7.4% | +11.1% | +1.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.